Top U.S. cancer centers have launched a federated AI platform, letting models learn from patient data securely to accelerate research and treatment discoveries.
The Galleri test, by American company GRAIL, can detect over 50 types of cancerous DNA with a simple blood test. How the cancer screening test works.
Cancer health tech company Flatiron Health has unveiled six new blood cancer data sets that together comprise information ...
Researchers from Rutgers Cancer Institute, New Jersey’s only National Cancer Institute (NCI) - designated Comprehensive ...
Oracle Health and Life Sciences is partnering with the Cancer Center Informatics Society to develop new AI applications aimed at improving cancer care and research. The partnership combines Oracle’s ...
DermaSensor announced newly published studies supporting the performance of its device for evaluating suspicious skin lesions ...
As Breast Cancer Awareness Month continues to gain attention across Europe, new initiatives are underway to strengthen early ...
According to data from the National Institute on Minority Health and Health Disparities, Louisiana had the eighth-highest ...
Prescriptions for GLP-1 receptor agonists in cancer patients have increased despite lack of clinical guidance. The overall ...
Nouscom Presents New Positive Phase 1/2b data of NOUS-209 at SITC 2025, Supporting Plans to Initiate Registration-Enabling ...
Experts explore the messy intersection between evidence-based cancer care and an enticing wellness industry dominated by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback